June 13, 2022
WASHINGTON – U.S. federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under five, a key step toward a long-awaited decision to begin vaccinating the youngest American children.
The Food and Drug Administration posted its analysis of the Pfizer shot ahead of a Wednesday meeting where outside experts will vote on whether the shots are ready for the nation’s 18 million babies, toddlers and preschoolers. Kids under five are the only group not yet eligible for COVID-19 vaccination in the U.S.
Late last week the FDA posted a similar analysis of Moderna’s shots for children under six.
If regulators clear the shots by one or both companies, vaccinations could begin as soon as next week with the drugmakers ready to rapidly ship doses ordered by the government. Parents have been pressing federal officials for months for the opportunity to protect their smallest children as more adults shed masks and abandon other public health precautions.